PATENT CLAIM ANALYSIS

Application Number: 16246231
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-05
Patent Classification: ["514", "171000"]

Abstract:
The present disclosure relates to methods for the treatment of sarcoidosis. In certain aspects and embodiments, the disclosure provides compositions containing 1,3-propanedisulfonic acid or a pharmaceutically acceptable salt thereof and/or the use of such compositions for the treatment of Sarcoidosis. In another aspect, the disclosure relates to compositions containing 1,3-propanedisulfonic acid or a pharmaceutically acceptable salt thereof plus a second active agent. In yet another aspect, the disclosure relates to kits containing agents useful for the treatment of sarcoidosis.

Claim (Index 15):
The composition of  claim 14  wherein said second agent is a corticosteroid.

Metadata:
- Claim Count in Document: 35.0
- Percentile: 99.0
- Lexical Diversity: 2.0
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['11643946', '11405348', '10871543', '13389606', '14795123']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7782688970904459
- 35 USC 102 Novelty (BERT): 0.5176247477168016
- Combined Prediction Score: 0.7522044821530814
- Mean Citation Score: 225.09699
- Max Citation Score: 249.09056
- Similarity Product: 137.3157690048218

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test